# AngioDynamics (ANGO) - Q2 2026 earnings

Reported January 6, 2026.

| | Reported | Consensus estimate |
| --- | --- | --- |
| Revenue | $79.4M | $76.4M |
| EPS | $-0.15 | $-0.10 |

Earnings filing reader: [8-K 0001140361-26-000341](https://www.opencapital.sh/filings/0001140361-26-000341)
Agent-readable filing: [Markdown](https://www.opencapital.sh/filings/0001140361-26-000341.md)
Original filing: [SEC.gov filing index](https://www.sec.gov/Archives/edgar/data/1275187/000114036126000341/0001140361-26-000341-index.htm)
Periodic report: 10-Q - https://www.sec.gov/Archives/edgar/data/1275187/000127518726000003/0001275187-26-000003-index.htm
Canonical page (please cite this URL): https://www.opencapital.sh/stocks/ango/earnings/q2-2026